Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network meta-analysis

BACKGROUND: Pulmonary arterial hypertension (PAH) is a fatal disease characterized by pulmonary vascular remodeling and increased pulmonary artery pressure, leading to impaired lung oxygenation, right heart failure, and even death. Although great advances have been made in PAH-targeted medications f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Fen, Wu, Kun, Zhu, Yong-zhi, Jiang, Jun-jun, Zhang, Gui, Liu, Jun, Xiao, Ping, Tian, Yang, Zhang, Wei, Zhang, Sheng, Hou, Feng, Bao, Zhong-wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875131/
https://www.ncbi.nlm.nih.gov/pubmed/36712266
http://dx.doi.org/10.3389/fcvm.2022.1055897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875131/
https://www.ncbi.nlm.nih.gov/pubmed/36712266
http://dx.doi.org/10.3389/fcvm.2022.1055897

Ejemplares similares